Ticker Details
Day One Biopharmaceuticals, Inc.
IPO Date:	May 27, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.04B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.42 | 2.85%
Avg Daily Range (30 D):	$0.34 | 3.65%
Avg Daily Range (90 D):	$0.26 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	.8M
Avg Daily Volume (30 D):	2.42M
Avg Daily Volume (90 D):	1.97M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	107
Avg Trade Size (Sh.) (90 D):	101

Institutional Trades
Total Institutional Trades:	1,688
Avg Institutional Trade:	$1.59M
Avg Institutional Trade (30 D):	$2.31M
Avg Institutional Trade (90 D):	$1.78M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.83M
Avg Closing Trade (30 D):	$2.69M
Avg Closing Trade (90 D):	$1.92M
Avg Closing Volume:	143.98K

News

Jan 6, 2026 @ 2:02 PM Day One Completes Acquisition of Mersana Therapeut... Source: Globe Newswire

Nov 13, 2025 @ 3:15 PM Day One Biopharma Expands Oncology Pipeline With $... Source: Vandana Singh

Nov 13, 2025 @ 11:00 AM Day One to Acquire Mersana Therapeutics to Advance... Source: Day One Biopharmaceuticals

Aug 5, 2025 @ 8:00 PM Day One Reports Second Quarter 2025 Financial Resu... Source: Day One Biopharmaceuticals

Oct 22, 2024 @ 6:33 PM Global Cancer Antibody Drug Conjugates Market Size... Source: Kuick Research

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.52	$-.19	$-.29
Diluted EPS	$-1.52	$-.19	$-.29
Revenue	$133.67M	$39.8M	$33.91M
Gross Profit
Net Income / Loss	$-72.79M	$M	$-30.32M
Operating Income / Loss	$-165.62M	$-24.25M	$-34.97M
Cost of Revenue
Net Cash Flow	$-379.49M	$7.66M	$-89.35M
PE Ratio